A report on NASA's commercial low-Earth-orbit destinations program quotes a Boeing representative discussing pricing conversations with CLD suppliers.
A BBC report reviews the mixed record of SpaceX's Starship program through its series of test launches.
This week's rocket roundup looks at signs that launch prices may be rising again, plus Astra's plan to return to flight in early 2027.
The panel examined data on spacewalk-related health risks, including decompression sickness, venous thromboembolism, and a heart condition known as patent foramen ovale.
The agencies will discuss the spacecraft's progress and plans for regular crew flights to the International Space Station.
Astronauts aboard the International Space Station will take part in a series of biomedical investigations examining how spaceflight affects the human body.
The decision-support tool helps NASA anticipate medical risks tied to cosmic radiation, microgravity and long-duration spaceflight, according to the agency.
The company reports its next-generation rocket has cleared final reviews ahead of an attempt to reach orbit, a milestone yet to be achieved by the Starship program.
The mission will also mark the first attempt to deploy next-generation V3 Starlink satellites, according to a TechCrunch report.
Report says space agency plans more missions for the capsule and will help certify a new rocket to keep it flying, despite earlier setbacks.
The startup says the new Series E financing will support efforts to reach orbit and develop a larger rocket, positioning it as a potential competitor to SpaceX in rocket reusability.
Weekly roundup notes engine installation for NASA's Artemis III mission, a debris-generating breakup of a Chinese Long March 6C stage, and new fundraising announcements from European launch startups.